|
Jan 29
|
Jim Cramer Says Novo Nordisk A/S (NVO) Is ‘Down So Much’
|
|
Jan 29
|
Is Eli Lilly and Company (LLY) the Best Stock to Buy in 2025 for Beginners?
|
|
Jan 29
|
Are Weight-Loss Drugs Like Gym Memberships? The Answer Is Worth Billions
|
|
Jan 28
|
Eli Lilly (LLY) Stock Drops Despite Market Gains: Important Facts to Note
|
|
Jan 28
|
Drugmakers Show Restraint on Price Increases in New Trump Era
|
|
Jan 28
|
Why Are Hedge Funds Bullish on Eli Lilly and Company (NYSE:LLY)?
|
|
Jan 28
|
How to Play NVO Stock After New Drug's Success in Obesity Study
|
|
Jan 28
|
Is There An Opportunity With Eli Lilly and Company's (NYSE:LLY) 43% Undervaluation?
|
|
Jan 28
|
Hims & Hers to Advertise Weight-Loss Shots at the Super Bowl
|
|
Jan 27
|
Winners and losers in Monday's DeepSeek shake-up
|
|
Jan 27
|
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
|
|
Jan 27
|
Trending tickers: Nvidia, Alphabet, Alibaba, Novo Nordisk and GSK
|
|
Jan 25
|
Got $5,000? 2 Top Healthcare Stocks to Buy in 2025 and Hold Forever.
|
|
Jan 25
|
Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.
|
|
Jan 24
|
Why Eli Lilly Stock Topped the Market Today
|
|
Jan 24
|
Novo Nordisk Surges As Next-Gen Obesity Drug Outperforms
|
|
Jan 24
|
Allurion Catapults 132% On Its Plans To Outdo Eli Lilly, Novo Nordisk
|
|
Jan 24
|
Novo Nordisk stock surges 7% after Ozempic maker’s latest weight-loss drug shows promise
|
|
Jan 24
|
3 Richly Valued Stocks I'll Be Watching Like a Hawk in 2025
|
|
Jan 24
|
Novo Nordisk stock pops on phase I data for new weight-loss drug amycretin
|